Home / Share Price Target / Kilitch
Kilitch Drugs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Kilitch Drugs | |||
 | Symbol: KILITCH | ||
| Price: ₹327.35 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Kilitch Drugs Brief Company Overview
- 1.1: Kilitch Drugs (India) Limited: A Pharmaceutical Powerhouse
- 1.2: Kilitch Drugs Financial Performance
- 1.2.1: Is Kilitch Drugs A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Kilitch Drugs Share Price Target For 2024
- 2.1.1: Kilitch Drugs Share Price Target Table For 2024
- 2.1.2: Summary: Kilitch Drugs Share Price Prediction For 2024
- 2.2: Kilitch Drugs Share Price Target For 2025
- 2.2.1: Kilitch Drugs Share Price Target Table For 2025
- 2.2.2: Summary: Kilitch Drugs Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Kilitch Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Kilitch Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Kilitch Drugs Past Performance
Kilitch Drugs Brief Company Overview
Kilitch Drugs (India) Limited: A Pharmaceutical Powerhouse
With a rich history dating back to 1978, Kilitch Drugs (India) Limited has established itself as a leading player in the Indian pharmaceutical industry. Headquartered in Mumbai, the company boasts a diverse product range catering to various therapeutic areas.
Diverse Product Range:
- Injectable Products: Parenteral and nasal formulations, including gastroenterology, anti-inflammatory, and anti-infective drugs.
- Oral Formulations: Tablets, capsules, and powders covering antibiotics, anti-diabetics, and cardiovascular medications.
- Effervescent Products: ROIPAR, DUREGRA, and other effervescent tablets and powders.
- Nutritional Products: CELTINE, a nutritional supplement.
- Topical Skin Adhesive: C-Seal, a solution for wound closure.
- Cosmetics and Herbal Products: A range of oils, lotions, and herbal products for skin, personal, and hair care.
Commitment to Innovation: Kilitch Drugs is driven by a commitment to developing and delivering high-quality pharmaceutical products. The company's dedicated research and development team ensures the continuous advancement of its product portfolio.
Advertisement
Kilitch Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 540.35 Crore | Market valuation of Kilitch Drugs's shares. |
| Revenue (TTM) | 151.26 Crore | Total revenue generated by Kilitch Drugs over the past twelve months. |
| Net Income (TTM) | +12.58 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 2.41% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 8.31% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -8.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -60.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 18.01 | Company's total debt divided by total shareholder equity. |
| Total Debt | 31.64 Crore | Sum of Kilitch Drugs's current & long-term financial obligations. |
| Total Cash | 69.07 Crore | Total amount of liquid funds available to Kilitch Drugs. |
| Beta | 0.24 | Beta is less than 1 indicating that the Kilitch Drugs's price is less volatile than the market. |
Is Kilitch Drugs A Good Buy For Long Term?
No valid response content found
To predict the Kilitch Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Kilitch Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Kilitch Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kilitch Drugs shares in 2024, see the table below.
Advertisement
Kilitch Drugs Share Price Target Table For 2024
| Kilitch Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 339.25 (+3.63%) | Price Action: Oct 2024 High |
| 2024 Target 2 | 335.45 (+2.47%) | Price Action: 03 Oct 2024 Low |
| 2024 Target 1 | 332.00 (+1.42%) | Price Action: 09 Oct 2024 Low |
| Current Price | 327.35 | Kilitch Drugs's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 321.70 (-1.73%) | Price Action: Mar 2024 Low |
| Stop Loss 2 | 315.77 (-3.54%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 311.86 (-4.74%) | Fibonacci Retracement Extended 40% |
Summary: Kilitch Drugs Share Price Prediction For 2024
In summary, Kilitch Drugs has declined by ₹-41.95, recording a notable -11.36% decrease from 1st January 2024 to 17 Oct 2024. Despite the setback, our analysis of Kilitch Drugs for 2024 predicts an additional rise of 1.42% to 3.63% by the end of 2024 with three potential targets T1: 332.00, T2: 335.45, T3: 339.25. Stop Loss at SL1: 321.70, SL2: 315.77, SL3: 311.86.
Kilitch Drugs has a 52-week high of ₹470.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹247.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Kilitch Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Kilitch Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Kilitch Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kilitch Drugs shares in 2025, see the table below.
Advertisement
Kilitch Drugs Share Price Target Table For 2025
| Kilitch Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 525.57 (+60.55%) | Price Action: Chart |
| 2025 Target 2 | 515.77 (+57.55%) | Price Action: Chart |
| 2025 Target 1 | 510.66 (+55.99%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 327.35 | Kilitch Drugs's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 281.00 (-14.16%) | Price Action: Nov 2023 Low |
| Stop Loss 2 | 277.00 (-15.39%) | Price Action: Oct 2023 High |
| Stop Loss 3 | 272.01 (-16.91%) | Price Action: Chart |
Summary: Kilitch Drugs Share Price Prediction For 2025
In summary, Kilitch Drugs has declined by ₹-41.95, recording a notable -11.36% decrease from 1st January 2024 to 17 Oct 2024. Despite the setback, our analysis of Kilitch Drugs for 2025 predicts an additional rise of 55.99% to 60.55% by the end of 2025 with three potential targets T1: 510.66, T2: 515.77, T3: 525.57. Stop Loss at SL1: 281.00, SL2: 277.00, SL3: 272.01.
Kilitch Drugs has a All-Time high of ₹470.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹247.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Kilitch Drugs, we have created a specific page for that check here: Kilitch Drugs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Kilitch Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Kilitch Drugs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.39% over the next 15 years.
For complete year by year Kilitch Drugs long term share price target from 2024, 2025 to 2039 check the below table.
Kilitch Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Kilitch Drugs Target | YoY Change % |
|---|---|---|
| 2024 | ₹327.35 | [Current Price] |
| 2024 | ₹398.77 | 21.81% |
| 2025 | ₹357.4 | -10.38% |
| 2026 | ₹385.87 | 7.96% |
| 2027 | ₹382.79 | -0.8% |
| 2028 | ₹445.84 | 16.47% |
| 2029 | ₹448.15 | 0.51% |
| 2030 | ₹400.59 | -10.62% |
| 2031 | ₹431.4 | 7.69% |
| 2032 | ₹426.91 | -1.05% |
| 2033 | ₹496.07 | 16.2% |
| 2034 | ₹497.52 | 0.29% |
| 2035 | ₹443.77 | -10.81% |
| 2036 | ₹476.92 | 7.47% |
| 2037 | ₹471.03 | -1.24% |
| 2038 | ₹546.29 | 15.97% |
| 2039 | ₹483.73 | -11.46% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Kilitch Drugs Past Performance
- In 2010, Kilitch Drugs opening price was ₹129
- As of Thu 17 Oct 2024 the price stands at ₹327.35.
- This represents a Compound Annual Growth Rate (CAGR) of 6.4%.
- In 14 years, an investment of 10,000 would have become ₹25,375.96.
As we wrap up, we hope you like our study on Kilitch Drugs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
